Stay updated on Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.5.4, representing an updated version of the page. The study details and displayed information remain unchanged.SummaryDifference0.1%

- Check19 days agoChange DetectedRevision label on the study record was updated from v3.5.2 to v3.5.3, indicating a minor metadata update. It does not alter the study data or visible content on the page.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision metadata updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check69 days agoChange DetectedAdded the Hepatocellular carcinoma tag, added a resource link to the Genetic and Rare Diseases Information Center, and updated the site revision from 3.4.3 to 3.5.0.SummaryDifference0.2%

- Check76 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. No user-facing content changes are evident.SummaryDifference0.1%

- Check105 days agoChange DetectedDeleted notices include a government funding status warning and the prior site revision note (v3.4.1); a new site revision (v3.4.2) has been added. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Liver Cancer Clinical Trial page.